GLP-1s are used to treat a wide range of conditions, including type 2 diabetes, obesity, sleep apnea, chronic kidney disease, a form of fatty liver disease called MASH and risk reduction related to cardiovascular events
These residual hCG levels can affect urine test results
The liquid solution is far more fragile, and a new set of rules applies
Diet quality, physical activity level, sleep patterns, and stress management all interact with medication effects to determine actual weight loss velocity
Category-wise Analysis By Product, Ozempic Dominates the GLP-1 Receptor Agonist Market Ozempic (semaglutide) dominates with 32.1% share of the global market in 2025 , due to its strong efficacy in both glycemic control and weight management
Physician-supervised compounded tirzepatide and retatrutide with provider-led dose titration, quarterly check-ins, and an included annual DEXA scan